pharmaphorum
MAY 9, 2022
SparkRx is designed to decrease depression in individuals aged 13 to 22 by providing a multi-week programme based on cognitive behavioural therapy (CBT) and behavioural activation protocols. “In In primary care, there are guidelines to screening for behavioural health concerns like depression annually. About the author .
pharmaphorum
MARCH 3, 2022
Originally set up with a focus on diabetes, Dario has added capabilities in hypertension, weight management, and musculoskeletal and behavioural health in the intervening years, for example by acquiring musculoskeletal wearable company Upright Technologies and digital behavioural health specialist wayForward last year.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
SEPTEMBER 24, 2020
An artificial intelligence-powered diagnostic for autism spectrum disorder (ASD), developed by Cognoa, has met all its objectives in a pivotal trial and will be filed for approval with the FDA. Cognoa has revealed however that the trial suggests the app is highly accurate across males and females as well as ethnic and racial backgrounds.
pharmaphorum
JANUARY 26, 2021
From telehealth to digital trials, customer engagement to healthcare data, Healthware Group outlines the key trends that are expected to shake up digital health this year. Clinical trials get more and more digitalised. Aging in place’ becomes more commonplace.
pharmaphorum
APRIL 23, 2021
grant, administered by OhioMHAS, and part of the US Department of Health and Human Services’ Substance Abuse and Mental Health Services Administration (SAMHSA) SOR grant programme for people in need of prevention, treatment and recovery support for opioid use disorder. Funding is provided by the State Opioid Response (SOR) 2.0
pharmaphorum
JANUARY 27, 2022
Immersive technology can also help improve assessments of the effectiveness of treatment, particularly regarding behavioural health where a patient’s results are often subjective. The book notes pharma can utilise VR for clinical trials as it allows for a better understanding of the research subject.
pharmaphorum
APRIL 25, 2022
Gani started BehaVR in 2016 to create DTx for mental and behavioural health. He says after a meeting between him and a leader at Sumitomo in 2018 or 2019, it became apparent both companies believed in the power of VR in mental health care. They also understand how to do clinical trial design,” Gani states.
Expert insights. Personalized for you.
135 
Let's personalize your content